FGEMX | VTCAX | FGEMX / VTCAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 6 years | 20 years | - |
Gain YTD | 31.777 | 37.607 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.71B | 4.64B | 37% |
Annual Yield % from dividends | 0.00 | 0.94 | - |
Returns for 1 year | 34.34 | 39.82 | 86% |
Returns for 3 years | 29.19 | 21.85 | 134% |
Returns for 5 years | 66.94 | 72.50 | 92% |
Returns for 10 years | N/A | 92.70 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFIX | 12.93 | 0.02 | +0.15% |
AlphaCentric Life Sciences & Hlthcare I | |||
FSERX | 19.29 | -0.07 | -0.36% |
Franklin Real Estate Securities R6 | |||
EQTIX | 17.92 | -0.09 | -0.50% |
Shelton Equity Income Investor | |||
PRIAX | 26.48 | -0.18 | -0.68% |
Principal Glb Emerging Markets A | |||
ERASX | 43.53 | -0.46 | -1.05% |
Eaton Vance Atlanta Capital SMID-Cap R6 |